| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/06/2006 | CN1827172A Pig viral infectious disease gene recombined live vaccine using canine II type adenovirus as carrier and preparation process thereof |
| 09/06/2006 | CN1827161A Method for preparing trichosanthin injection |
| 09/06/2006 | CN1827144A Externally applied Chinese medicinal mixture for treating onychomycosis |
| 09/06/2006 | CN1827139A Liver beneficial pharmaceutical composition and method for preparing the same |
| 09/06/2006 | CN1827133A Medicine for treating dermatopathy and its preparing process |
| 09/06/2006 | CN1827127A Extraction method and technique of olive leaf extract |
| 09/06/2006 | CN1827126A Chinese medicinal composition for treating viral infection of upper respiratory tract and preparing process thereof |
| 09/06/2006 | CN1827122A Quality control method of heat-clearing toxin-removing cold-treating honeysuckle injection |
| 09/06/2006 | CN1827118A Method for preparing nanometer realgar gel and nanometer realgar with biomacromolecule template to regulate shape and particle thereof |
| 09/06/2006 | CN1827115A Film-coated tablet of glycyrrhizinic acid monopotassiium salt and method for preparing the same |
| 09/06/2006 | CN1827102A Bilogical adhesive tablet of ornidazole and method for preparing the same |
| 09/06/2006 | CN1827093A Taurine injection and method for preparing the same |
| 09/06/2006 | CN1827088A Preparation method of Chinese medicinal injection for treating hepatitis and injection prepared thereby |
| 09/06/2006 | CN1273828C Detection method for capsule for treating cold and cough |
| 09/06/2006 | CN1273598C Bactericidal/permeability-increasing protein delation analogs |
| 09/06/2006 | CN1273593C Gene cloning of polyepitope antigen of hepatitis C virus and its coding sequence |
| 09/06/2006 | CN1273478C Novel nucleosides and oligonucleotide analogues |
| 09/06/2006 | CN1273476C Oligonucleotide analoguse |
| 09/06/2006 | CN1273475C 6-0-substituted ketolides having antibacterial activity |
| 09/06/2006 | CN1273470C Polycyclic xanthones as antibiotics |
| 09/06/2006 | CN1273452C 7-(4,4-dimethyl-3-aminomethylpentazane-1-yl) substituted quinoline carboxylic acid derivative and its preparation |
| 09/06/2006 | CN1273193C Method for preparing biologics of yolk antibody for resisting Helicobacter Pylori |
| 09/06/2006 | CN1273190C 疫苗组合物 Vaccine composition |
| 09/06/2006 | CN1273189C West nile vaccine |
| 09/06/2006 | CN1273186C Method for preparing injection without needle of interferon |
| 09/06/2006 | CN1273183C Method for extracting effective constituent from Sand Ginger by bi-enzyme method |
| 09/06/2006 | CN1273180C Medicine for treating arthritis |
| 09/06/2006 | CN1273154C Medicine for treating cold |
| 09/06/2006 | CN1273149C Medication for preventing hospital infection and method of preparing oral fluid thereof |
| 09/06/2006 | CN1273142C Ethanolate of azithromycin, its preparation method and pharmaceutical compositions thereof |
| 09/06/2006 | CN1273139C Soft capsule of levogyrate ofloxacin and preparation method |
| 09/06/2006 | CN1273138C Sustained-release preparations of quinolone antibiotics and preparation method thereof |
| 09/06/2006 | CN1273134C Soft capsule of fibrauretine and preparation method thereof |
| 09/06/2006 | CN1273133C Berberine hydrochloride granule for masking flavor and its preparation |
| 09/06/2006 | CN1273117C Controlled-releasing sticking plaster of natural interferon |
| 09/06/2006 | CN1273110C System treatment of a mucosal surface |
| 09/05/2006 | USRE39267 Thienopyrimidine-based inhibitors of the SRC family |
| 09/05/2006 | USRE39264 Pharmaceutical combination |
| 09/05/2006 | US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative |
| 09/05/2006 | US7102009 For treating cancer and angiogenesis-related disorders |
| 09/05/2006 | US7102007 Dihydroindole and tetrahydroquinoline derivatives |
| 09/05/2006 | US7101995 Drug delivery to inhibit abnormal gene expression in mammalian cells; small interfering RNAs (siRNA) |
| 09/05/2006 | US7101990 Bax-responsive genes for drug target identification in yeast and fungi |
| 09/05/2006 | US7101974 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 09/05/2006 | US7101964 Vancomycin derivatives provide enhanced antibacterial activity, selectivity and reduced mammalian toxicity |
| 09/05/2006 | US7101908 Nontoxic treatment for infections from cytomegalovirus |
| 09/05/2006 | US7101900 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides |
| 09/05/2006 | US7101899 N-[4-[2-Ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide; adenosine A3 receptor antagonistic activity |
| 09/05/2006 | US7101894 Administering quinoline derivative for therapy of Cytomegalovirus infections in human pathogen |
| 09/05/2006 | US7101882 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 09/05/2006 | US7101874 1) N-[[(5S)-3-[4-(2,3-dihydro-1,1-dioxido-4H-1,4-thiazin-4-yl)-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; potent activities against Gram-positive and Gram-negative bacteria |
| 09/05/2006 | US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor |
| 09/05/2006 | US7101861 For therapy and prophylaxis of host infected with flavivirus or pestivirus |
| 09/05/2006 | US7101860 Composition and method for inhibiting platelet aggregation |
| 09/05/2006 | US7101856 Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 09/05/2006 | US7101851 IgE receptor antagonists |
| 09/05/2006 | US7101711 Activating a T gamma 9 delta 2 lymphocyte at a minimum activation concentration of below 100 nM, in vitro by contacting with a 3,4-epoxy-3-methyl-1-butyl diphosphate substituted with a biomolecule |
| 09/05/2006 | US7101560 Combination vaccine for administration to adolescents |
| 09/05/2006 | US7101555 Microorganismal polypeptides for use in diagnosis and treatment of respiratory system disorders; genetic vaccines |
| 09/05/2006 | US7101554 Picornaviruses, vaccines and diagnostic kits |
| 09/05/2006 | US7101553 Administering prebiotic such as fructo-oligosaccharide; measles prevention; vaccines; nutrients |
| 09/05/2006 | US7101551 Substance which inhibits binding between E2/NS1 protein of hepatitis C virus and cell infectious with hepatitis C virus, a cell expressing CD81, or CD81 |
| 09/05/2006 | US7101550 Agents for modulating PD-1, B7-4, and the interaction between B7-4 and PD-1 in order to modulate a costimulatory or an inhibitory signal in a immune cell resulting in modulation of the immune response |
| 09/05/2006 | US7101548 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology |
| 09/05/2006 | CA2246668C Low ph germicidal iodine compositions having enhanced stability |
| 09/05/2006 | CA2143642C Immunoreactive peptides from epstein-barr virus |
| 09/05/2006 | CA2099707C Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins |
| 08/31/2006 | WO2006091905A1 Bicyclo (3.1.0) hexane derivatives as antiviral compounds |
| 08/31/2006 | WO2006091858A1 Benzisothiazoles useful for treating or preventing hcv infection |
| 08/31/2006 | WO2006091692A1 Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors |
| 08/31/2006 | WO2006091669A1 Anti-cancer and anti-microbial oxazolidinones and analogues |
| 08/31/2006 | WO2006091534A1 Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors |
| 08/31/2006 | WO2006091112A1 Compositions for the delivery of rna interference molecules and methods for their use |
| 08/31/2006 | WO2006090906A1 NOVEL METHOD FOR OVERCOMING RNAi-RESISTANT STRAIN OF VIRUS |
| 08/31/2006 | WO2006090853A1 Nitrogenous heterocyclic compound and medicinal use thereof |
| 08/31/2006 | WO2006090816A1 Method of constructing liposome vaccine |
| 08/31/2006 | WO2006090729A1 Fermented tea beverage and tea beverage |
| 08/31/2006 | WO2006090150A1 Pharmaceutical composition comprising amorphous rosiglitazone |
| 08/31/2006 | WO2006090143A1 4-0x0quinaz0lin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 08/31/2006 | WO2006089942A1 Protease inhibitor precursor synthesis |
| 08/31/2006 | WO2006089746A1 Purification process |
| 08/31/2006 | WO2006089664A2 Heterocyclylamide-substituted imidazoles |
| 08/31/2006 | WO2006035068A3 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 08/31/2006 | WO2005120577A3 Derivatives of chemotherapeutic agents with a formaldehyde releasing moeity |
| 08/31/2006 | US20060194870 1-((4,14-(Dioxo),5-(1-hydroxy,1,2-dicarboxyethyl)),3-azaoctadec-6-enyl-),4-(phenoxy)benzene derivatives and salts ; extremely potent replication inhibitory activity against the hepatitis C virus (HCV); chronic hepatitis, cirrhosis and liver cancer; mild cytotoxicity in vitro; prophylaxis; prodrugs |
| 08/31/2006 | US20060194864 Indole derivatives |
| 08/31/2006 | US20060194848 Substituted amine derivatives and methods of use |
| 08/31/2006 | US20060194843 4-(2,6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide; anticancer agents; carcinoma of the colon; antifungal agents; antitumor agents; infections; 4-(2,6-difluoro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methyl-piperidin-4-yl)-amide |
| 08/31/2006 | US20060194804 Hiv replication inhibiting pyrimidines and triazines |
| 08/31/2006 | US20060194787 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 08/31/2006 | US20060194755 Compositions and methods for regulating an immune response in a subject |
| 08/31/2006 | US20060194745 Compounds and methods for inhibiting selectin-mediated function |
| 08/31/2006 | US20060194732 Lipid-free powder form of surfactant protein A with a carrier; microbiocides; antiinflammatory and bronchodilator agents |
| 08/31/2006 | US20060194717 reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release; side effect reduction |
| 08/31/2006 | US20060194716 Polyacid glycopeptide derivatives |
| 08/31/2006 | US20060194714 Novel depsipeptides and process for preparing same |
| 08/31/2006 | US20060193876 Fusion proteins of Mycobacterium tuberculosis |
| 08/31/2006 | US20060193875 Method of treating human-immunodeficiency virus (hiv) disease infection |
| 08/31/2006 | US20060193874 Vaccines for proliferative ileitis and methods of making and using the same |
| 08/31/2006 | US20060193873 Functionallly reconstituted viral membranes containing adjuvant |